Sobi, an international pharmaceutical company, localizes the production of the first long-acting recombinant blood factor VIII registered in Russia for the treatment of hemophilia A at the Skopinpharm facility in the Ryazan Region. Investments in the project will total RUB 1 bn, the Government of the Ryazan Region told TASS on Tuesday.
According to the Ryazan Region governor Nikolay Lyubimov, Thai agricultural conglomerate CP Group will begin building pig farms in three areas in the Ryazan Region with total cost of about 7 billion rubles in 2020.
Fliegl Agrartechnik GmbH, a German company, will open its first Russian production facility of agricultural machinery in the Ryazan Region. On August 30, Governor Nikolai Lyubimov met with its owner Josef Fliegl, reports the regional Government.
Doshirak, the Korean producer of instant foods, will invest ₽1.5 billion in modernization of the plant in Ryazan. Production development will additionally provide employment opportunities for one hundred people, the press office of the government of the Ryazan region reported on Friday.
Doshirak (Korea) will increase instant noodles production capacity by more than a third at its plant in Ryazan. Implementation of the investment project will start in 2020, Andrei Vorfolomeev, Minister of Industry and Economic Development of Ryazan region, told TASS on Monday.
The international pharmaceutical company MSD and the Russian company Fort agreed to cooperate in the phased localization of the rotavirus infection, chicken pox, and human papillomavirus (HPV) prevention vaccine production. Investments will amount to RUB 7 billion. This is stated in a joint statement by the companies.